As Of | Issuer | Filings # Latest | With Filer (Primary) |
---|
| |
---|
4/25/24 | | | Protara Therapeutics, Inc. | 5 | SC 13G | | Ra Capital Management, L.P. |
---|
4/15/24 | | | Surrozen, Inc./DE | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
4/12/24 | | | Eliem Therapeutics, Inc. | 5 | SC 13D/A | | Ra Capital Management, L.P. |
---|
4/12/24 | | | Boundless Bio, Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
4/11/24 | | | CervoMed Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
4/11/24 | | | Acrivon Therapeutics, Inc. | 3 | SC 13D/A | | Ra Capital Management, L.P. |
---|
4/4/24 | | | Dyne Therapeutics, Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
4/1/24 | | | Sera Prognostics, Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
3/29/24 | | | Nkarta, Inc. | 2 | SC 13D/A | | Ra Capital Management, L.P. |
---|
3/29/24 | | | ARS Pharmaceuticals, Inc. | 3 | SC 13D/A | | Ra Capital Management, L.P. |
---|
3/29/24 | | | Alto Neuroscience, Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
3/28/24 | | | LENZ Therapeutics, Inc. | 1 | SC 13D | | Ra Capital Management, L.P. |
---|
3/25/24 | | | Regulus Therapeutics Inc. | 5 | SC 13G | | Ra Capital Management, L.P. |
---|
3/25/24 | | | Cybin Inc. | 1 | SC 13G | | Ra Capital Management, L.P. |
---|
3/11/24 | | | PepGen Inc. | 4 | SC 13D/A | | Ra Capital Management, L.P. |
---|
3/6/24 | | | Janux Therapeutics, Inc. | 2 | SC 13D/A | | Ra Capital Management, L.P. |
---|
3/6/24 | | | 89bio, Inc. | 7 | SC 13D/A | | Ra Capital Management, L.P. |
---|
2/27/24 | | | Connect Biopharma Holdings Ltd. | 6 | SC 13D/A | | Ra Capital Management, L.P. |
---|
2/26/24 | | | Larimar Therapeutics, Inc. | 4 | SC 13G | | Ra Capital Management, L.P. |
---|
2/21/24 | | | Icosavax, Inc. | 3 | SC 13D/A | | Ra Capital Management, L.P. |
---|
| | | More... Please Sign In to list all 225 of them. |